A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma

NCT04813354 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DEVICE: ELLIPTA
DEVICE: BREEZHALER

Sponsor

GlaxoSmithKline